INSMED Inc — Director's Dealing 2017

Jun 1, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2017-05-30

Reporting Person: Pellizzari Christine A (General Counsel & Corp. Sec.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-05-30	Common Stock	P	7300	$15.23	Acquired	27300	Direct
2017-05-31	Common Stock	P	2700	$14.89	Acquired	30000	Direct

Footnotes

F1: The price in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $15.14 to $15.30, inclusive. The reporting person undertakes to provide to Insmed Incorporated, any security holder thereof, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and footnote (2).

F2: The price in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $14.83 to $14.96, inclusive.